← Open Payments lookup

BENJAMIN SAXEY: Open Payments

NPI 1225482201 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,644 in 90 payments from 17 companies in 2025. Trend: 2023 $1,282 · 2024 $1,440 · 2025 $1,644

Food & beverage: $1,644
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.13$287
Teva Pharmaceuticals USA, Inc.14$206
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$202
Neurocrine BioSciences, Inc.8$164
ABBVIE INC.13$163
Janssen Pharmaceuticals, Inc8$144
Takeda Pharmaceuticals U.S.A., Inc.5$127
Axsome Therapeutics, Inc.5$92
Alkermes, Inc.4$78
Biogen, Inc.2$39

Products named: FANAPT, CAPLYTA, INGREZZA, VRAYLAR, AUSTEDO XR, TRINTELLIX, Auvelity, SPRAVATO.

Industry payments across UT — which companies pay providers there.